Showing 541-560 of 746 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Perphenazine for schizophrenia
Cochrane Systematic Reviews, 6-Mar-2015
Perphenazine is an old phenothiazine antipsychotic with a potency similar to haloperidol. It has been used for many years and is popular in the northern European countries and Japan.
- Pharmacological and surgical interventions for the treatment of gastro‐oesophageal reflux in adults and children with asthma
Cochrane Systematic Reviews, 17-May-2021
Asthma and gastro-oesophageal reflux disease (GORD) are common medical conditions that frequently co-exist. GORD has been postulated as a trigger for asthma; however, evidence remains conflicting. Proposed mechanisms by which GORD causes asthma include di
- Pharmacological cardioversion for atrial fibrillation and flutter
Cochrane Systematic Reviews, 15-Nov-2017
Atrial fibrillation is the commonest cardiac dysrhythmia. It is associated with significant morbidity and mortality. There are two approaches to the management of atrial fibrillation: controlling the ventricular rate or converting to sinus rhythm in the e
- Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings
Cochrane Systematic Reviews, 18-Jun-2013
The items with X are considered "more relevant", that is the review has to stick to them to allow publication. The others have to be considered as strong suggestions to improve the readability and clarity of the review, but the reviewers can consider if
- Pharmacological interventions for borderline personality disorder
Cochrane Systematic Reviews, 16-Jun-2010
Drugs are widely used in borderline personality disorder (BPD) treatment, chosen because of properties known from other psychiatric disorders ("off-label use"), mostly targeting affective or impulsive symptom clusters.
- Pharmacological interventions for epilepsy in people with intellectual disabilities
Cochrane Systematic Reviews, 3-Sep-2015
The prevalence of epilepsy among people with intellectual disabilities is much higher than in the general population. Seizures in this population are often complex and refractory to treatment and antiepileptic medication may have a profound effect upon be
- Pharmacological interventions for hypertensive emergencies
Cochrane Systematic Reviews, 23-Jan-2008
Hypertensive emergencies, marked hypertension associated with acute end-organ damage, are life-threatening conditions. Many anti-hypertensive drugs have been used in these clinical settings. The benefits and harms of such treatment and the best first-line
- Pharmacological management for agitation and aggression in people with acquired brain injury
Cochrane Systematic Reviews, 13-May-2008
Of the many psychiatric symptoms that may result from brain injury, agitation and/or aggression are often the most troublesome. It is therefore important to evaluate the efficacy of psychotropic medication used in its management.
- Pharmacological treatment for psychotic depression
Cochrane Systematic Reviews, 7-Dec-2021
Evidence is limited regarding the most effective pharmacological treatment for psychotic depression: monotherapy with an antidepressant, monotherapy with an antipsychotic, another treatment (e.g. mifepristone), or combination of an antidepressant plus an
- Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia
Cochrane Systematic Reviews, 24-May-2021
This is an update of a Cochrane Review first published in 2006 (McGuinness 2006), and previously updated in 2009 (McGuinness 2009). Hypertension is a risk factor for dementia. Observational studies suggest antihypertensive treatment is associated with low
- Pharmacological treatments for psychosis‐related polydipsia
Cochrane Systematic Reviews, 18-Oct-2006
Polydipsia is the intake of more than three litres of fluids per day. Primary polydipsia occurs when excessive drinking cannot be explained by an identified medical condition, and is not secondary to polyuria. The prevalence of this problem in psychiatric
- Pharmacotherapy augmentation strategies in treatment-resistant anxiety disorders
Cochrane Systematic Reviews, 2-Nov-2008
A large proportion of patients with anxiety disorders fail to respond to first-line medication interventions, despite evidence of the effectiveness of these agents.
- Pharmacotherapy for Behcet's syndrome
Cochrane Systematic Reviews, 27-Apr-1998
Behcet's syndrome is a multisystemic disorder presenting with recurrent oral and genital ulcerations as well as ocular involvement. Treatment of Behcet's syndrome is symptomatic and empirical.
- Pharmacotherapy for dysthymia
Cochrane Systematic Reviews, 21-Jul-2003
Many drug treatments have been proposed for the treatment of dysthymia, but with so many potential comparisons it is not possible at the present time to determine which is the treatment of choice. There is a need to know whether the different classes of a
- Pharmacotherapy for hypertension in adults 60 years or older
Cochrane Systematic Reviews, 5-Jun-2019
This is the second substantive update of this review. It was originally published in 1998 and was previously updated in 2009. Elevated blood pressure (known as 'hypertension') increases with age - most rapidly over age 60. Systolic hypertension is more st
- Pharmacotherapy for patellofemoral pain syndrome
Cochrane Systematic Reviews, 19-Jul-2004
Patellofemoral pain syndrome (PFPS) is common among adolescents and young adults. It is characterised by pain behind or around the patella and crepitations, provoked by ascending or descending stairs, squatting, prolonged sitting with flexed knees, runnin
- Pharmacotherapy for post traumatic stress disorder (PTSD)
Cochrane Systematic Reviews, 25-Jan-2006
Post traumatic stress disorder (PTSD) is a prevalent and disabling disorder. Evidence that PTSD is characterised by specific psychobiological dysfunctions has contributed to a growing interest in the use of medication in its treatment.
- Pharmacotherapy for social anxiety disorder (SAnD)
Cochrane Systematic Reviews, 19-Oct-2017
Recognition is growing that social anxiety disorder (SAnD) is a chronic and disabling disorder, and data from early trials demonstrate that medication may be effective in its treatment. This systematic review is an update of an earlier review of pharmacot
- Phytoestrogens for menopausal vasomotor symptoms
Cochrane Systematic Reviews, 6-Dec-2013
Vasomotor symptoms, such as hot flushes and night sweats, are very common during the menopausal transition. Hormone therapy has traditionally been used as a highly effective treatment, but concerns about increased risk of some chronic diseases have marked
- Pimozide for schizophrenia or related psychoses
Cochrane Systematic Reviews, 5-Nov-2013
Pimozide, formulated in the 1960s, continues to be marketed for the care of people with schizophrenia or related psychoses such as delusional disorder. It has been associated with cardiotoxicity and sudden unexplained death. Electrocardiogram monitoring i
